European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
The aim of this presentation is to give an overview of the epidemiology of bacterial STIs in the EU/EEA and highlight some options for response based on published ECDC scientific advice documents.
Descriptive epidemiology data on chlamydia, lymphogranuloma venereum (LGV), syphilis and congenital syphilis and gonorrhoea were extracted from the respective annual epidemiological reports and the ECDC Surveillance Atlas (https://www.ecdc.europa.eu/en/surveillance-atlas-infectious-diseases). Trends in notified cases for 2009-2018 were described for countries that consistently reported during the period.
More than 500 000 cases of bacterial STIs were reported from the EU/EEA countries in 2018: 406 406 chlamydia, 2 389 LGV, 33 927 syphilis, 60 congenital syphilis and 100 673 gonorrhoea. There were large variations in the national notification rates for most of the infections. Trends of gonorrhoea, syphilis and LGV continued to increase, with a large proportion of cases among men who have sex with men (MSM). There was an increase in syphilis and gonorrhoea reports among the HIV-negative MSM cases. Young heterosexual populations continue to be primarily affected by chlamydia and gonorrhoea. Number of notified congenital syphilis cases increased in 2018 for the first time since 2013, although the overall EU/EEA and national rates remained below the elimination target.
In reaction to the increasing trends of STIs, ECDC has published a series of evidence-based scientific advice documents and technical reports. A national STI prevention and control strategy, primary prevention activities, evidence-based case management guidelines, effective partner notification services, targeted testing of risk groups, AMR monitoring of Neisseria gonorrhoeae are among the recommendations formulated by ECDC.
34 IUSTI Congress - European Congres on Sexually transmitted Infections and HIV/AIDS
TAMING THE TIDE of STIs & HIV
Bucharest, September 3-5,